BIOMAT Database Logo BIOMAT Database Logo

[Hyperlipidemias. Diet and drug therapy]. 1977

S Sailer

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D002792 Cholestyramine Resin A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion. Cholestyramine,Colestyramine,Colestyramin,Cuemid,MK-135,Quantalan,Questran,Cholestyramine Resins,Cholestyramines,Colestyramines,Colestyramins,Cuemids,MK 135,MK135,Quantalans,Questrans,Resin, Cholestyramine,Resins, Cholestyramine
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4

Related Publications

S Sailer
[Diet therapy of hyperlipidemias].
January 1972, Deutsches medizinisches Journal,
S Sailer
[Diet therapy of hyperlipidemias (hyperlipoproteinemias)].
May 1977, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
S Sailer
[Drug therapy of hyperlipidemias].
January 1981, Wiener medizinische Wochenschrift (1946),
S Sailer
Drug therapy. VI. Therapy of hyperlipidemias.
July 1970, Northwest medicine,
S Sailer
Drug therapy of the hyperlipidemias.
January 1985, Iowa medicine : journal of the Iowa Medical Society,
S Sailer
[Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
August 1973, Medizinische Klinik,
S Sailer
[Hyperlipidemias. Concern with the Mediterranean diet].
November 1999, Presse medicale (Paris, France : 1983),
S Sailer
Diet and drugs in the treatment of hyperlipidemias.
May 1970, The Medical letter on drugs and therapeutics,
S Sailer
[Hyperlipidemias: occurrence, significance, therapy].
August 1967, Die Medizinische Welt,
S Sailer
[Therapy of primary hyperlipidemias].
August 1971, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!